These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 11550118)

  • 1. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.
    Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE
    Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.
    Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE
    J Gen Intern Med; 2002 May; 17(5):377-81. PubMed ID: 12047736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.
    Farley J; Hines S; Musk A; Ferrus S; Tepper V
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):211-8. PubMed ID: 12794557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use and medication adherence among HIV-1 infected individuals.
    Hinkin CH; Barclay TR; Castellon SA; Levine AJ; Durvasula RS; Marion SD; Myers HF; Longshore D
    AIDS Behav; 2007 Mar; 11(2):185-94. PubMed ID: 16897351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
    Walsh JC; Mandalia S; Gazzard BG
    AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.
    Howard AA; Arnsten JH; Lo Y; Vlahov D; Rich JD; Schuman P; Stone VE; Smith DK; Schoenbaum EE;
    AIDS; 2002 Nov; 16(16):2175-82. PubMed ID: 12409739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting.
    Thirumurthy H; Siripong N; Vreeman RC; Pop-Eleches C; Habyarimana JP; Sidle JE; Siika AM; Bangsberg DR
    AIDS; 2012 Nov; 26(18):2399-403. PubMed ID: 22948266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to use of electronic adherence monitoring in an HIV clinic.
    Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
    Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.
    Llabre MM; Weaver KE; Durán RE; Antoni MH; McPherson-Baker S; Schneiderman N
    AIDS Patient Care STDS; 2006 Oct; 20(10):701-11. PubMed ID: 17052140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study.
    de Bruin M; Hospers HJ; van den Borne HW; Kok G; Prins JM
    AIDS Patient Care STDS; 2005 Jun; 19(6):384-94. PubMed ID: 15989434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues.
    Pearson CR; Simoni JM; Hoff P; Kurth AE; Martin DP
    AIDS Behav; 2007 Mar; 11(2):161-73. PubMed ID: 16804749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa.
    Müller AD; Bode S; Myer L; Roux P; von Steinbüchel N
    Pediatr Infect Dis J; 2008 Mar; 27(3):257-62. PubMed ID: 18277933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.
    Hugen PW; Langebeek N; Burger DM; Zomer B; van Leusen R; Schuurman R; Koopmans PP; Hekster YA
    J Acquir Immune Defic Syndr; 2002 Jul; 30(3):324-34. PubMed ID: 12131570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal recall period and response task for self-reported HIV medication adherence.
    Lu M; Safren SA; Skolnik PR; Rogers WH; Coady W; Hardy H; Wilson IB
    AIDS Behav; 2008 Jan; 12(1):86-94. PubMed ID: 17577653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.
    Applebaum AJ; Reilly LC; Gonzalez JS; Richardson MA; Leveroni CL; Safren SA
    AIDS Patient Care STDS; 2009 Jun; 23(6):455-62. PubMed ID: 19519229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.